| 1 | Autosomal dominant non-syndromic intellectual disability | Enrichment | EPB41L1, GRIN1, GRIN2B, KCNQ2 | 4.91 |
| 2 | Rett syndrome, congenital variant | Enrichment | GABBR2, NTNG1 | 3.65 |
| 3 | West syndrome | Enrichment | GRIN1, GRIN2B, KCNQ2 | 3.57 |
| 4 | Complex neurodevelopmental disorder | Enrichment | ATP2B1, GRIK2, GRIN2B, NTNG1 | 3.37 |
| 5 | Autosomal recessive non-syndromic intellectual disability | Enrichment | GRIK2, GRIN1, NCDN | 3.22 |
| 6 | Early infantile developmental and epileptic encephalopathy | Enrichment | CASK, GRIN1 | 2.92 |
| 7 | Developmental and epileptic encephalopathy 1 | Enrichment | GRIN1, KCNQ2 | 2.63 |
| 8 | Febrile seizures, familial, 8 | Enrichment | GABRG2 | 2.54 |
| 9 | Chromosome 20q11-q12 deletion syndrome | Enrichment | EPB41L1 | 2.54 |
| 10 | Intellectual developmental disorder, autosomal recessive 37 | Enrichment | ANK3 | 2.54 |
| 11 | Developmental and epileptic encephalopathy 7 | Enrichment | KCNQ2 | 2.54 |
| 12 | Developmental and epileptic encephalopathy 27 | Enrichment | GRIN2B | 2.54 |
| 13 | Elliptocytosis 1 | Enrichment | EPB41 | 2.54 |
| 14 | Neurodevelopmental disorder with infantile epileptic spasms | Enrichment | NCDN | 2.54 |
| 15 | Intellectual developmental disorder, autosomal dominant 66 | Enrichment | ATP2B1 | 2.54 |
| 16 | Neurodevelopmental disorder with impaired language and ataxia and with or without seizures | Enrichment | GRIK2 | 2.54 |
| 17 | Developmental and epileptic encephalopathy 74 | Enrichment | GABRG2 | 2.54 |
| 18 | Neurodevelopmental disorder with poor language and loss of hand skills | Enrichment | GABBR2 | 2.54 |
| 19 | Developmental and epileptic encephalopathy 59 | Enrichment | GABBR2 | 2.54 |
| 20 | Auriculocondylar syndrome 2a | Enrichment | PLCB4 | 2.54 |
| 21 | Agenesis of corpus callosum, cardiac, ocular, and genital syndrome | Enrichment | CDH2 | 2.54 |
| 22 | Intellectual developmental disorder, autosomal recessive 6 | Enrichment | GRIK2 | 2.54 |
| 23 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | Enrichment | GRIN1 | 2.54 |
| 24 | Familial hemophagocytic lymphohistiocytosis 5 | Enrichment | STXBP2 | 2.54 |
| 25 | Hemophagocytic lymphohistiocytosis, familial, 5, with or without microvillus inclusion disease | Enrichment | STXBP2 | 2.54 |
| 26 | Arrhythmogenic right ventricular dysplasia, familial, 14 | Enrichment | CDH2 | 2.54 |
| 27 | Intellectual developmental disorder, autosomal dominant 6, with or without seizures | Enrichment | GRIN2B | 2.54 |
| 28 | Spinocerebellar ataxia 37 | Enrichment | DAB1 | 2.54 |
| 29 | Charcot-marie-tooth disease, axonal, type 2ff | Enrichment | CADM3 | 2.54 |
| 30 | Developmental and epileptic encephalopathy 101 | Enrichment | GRIN1 | 2.54 |
| 31 | Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant | Enrichment | GRIN1 | 2.54 |
| 32 | Epilepsy, idiopathic generalized 16 | Enrichment | KCNMA1 | 2.54 |
| 33 | Cerebellar atrophy, developmental delay, and seizures | Enrichment | KCNMA1 | 2.54 |
| 34 | Auriculocondylar syndrome 2b | Enrichment | PLCB4 | 2.54 |
| 35 | Intellectual developmental disorder, autosomal dominant 59 | Enrichment | CAMK2G | 2.54 |
| 36 | Attention deficit-hyperactivity disorder 8 | Enrichment | CDH2 | 2.54 |
| 37 | Grin2b-related neurodevelopmental disorder | Enrichment | GRIN2B | 2.54 |
| 38 | Cask-related intellectual disability | Enrichment | CASK | 2.54 |
| 39 | Intellectual disability, autosomal dominant 8 | Enrichment | GRIN1 | 2.54 |
| 40 | Kcnq2-related disorders | Enrichment | KCNQ2 | 2.54 |
| 41 | Cerebral palsy | Enrichment | GPHN, GRIN2B | 2.25 |
| 42 | Seizures, benign familial neonatal, 1 | Enrichment | KCNQ2 | 2.24 |
| 43 | Seizures, benign familial neonatal, 2 | Enrichment | KCNQ2 | 2.24 |
| 44 | Hyperekplexia 1 | Enrichment | GPHN | 2.24 |
| 45 | Microcephalic osteodysplastic primordial dwarfism, type i | Enrichment | CLASP1 | 2.24 |
| 46 | Lowry-wood syndrome | Enrichment | CLASP1 | 2.24 |
| 47 | Fg syndrome 4 | Enrichment | CASK | 2.24 |
| 48 | Seizures, benign familial infantile, 3 | Enrichment | KCNQ2 | 2.24 |
| 49 | Keppen-lubinsky syndrome | Enrichment | KCNJ6 | 2.24 |
| 50 | Retinal dystrophy, juvenile cataracts, and short stature syndrome | Enrichment | GPHN | 2.24 |
| 51 | Roifman syndrome | Enrichment | CLASP1 | 2.24 |
| 52 | Bilateral generalized polymicrogyria | Enrichment | GRIN1 | 2.24 |
| 53 | Molybdenum cofactor deficiency, type c | Enrichment | GPHN | 2.24 |
| 54 | Syndromic x-linked intellectual disability | Enrichment | CASK | 2.24 |
| 55 | Ocular melanoma | Enrichment | PLCB4 | 2.24 |
| 56 | Ichthyosis, congenital, autosomal recessive 10 | Enrichment | KCNQ2 | 2.24 |
| 57 | Mitochondrial complex iv deficiency, nuclear type 12 | Enrichment | STXBP2 | 2.24 |
| 58 | Rnu4atac-opathy | Enrichment | CLASP1 | 2.24 |
| 59 | Liang-wang syndrome | Enrichment | KCNMA1 | 2.24 |
| 60 | Self-limited neonatal epilepsy | Enrichment | KCNQ2 | 2.24 |
| 61 | Cerebral visual impairment | Enrichment | GRIK2 | 2.24 |
| 62 | Benign epilepsy with centrotemporal spikes | Enrichment | GABRG2, GRIN1 | 2.21 |
| 63 | Centralopathic epilepsy | Enrichment | GABRG2, GRIN1 | 2.17 |
| 64 | Spondyloepiphyseal dysplasia congenita | Enrichment | CLASP1 | 2.07 |
| 65 | Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia | Enrichment | CASK | 2.07 |
| 66 | Paroxysmal nonkinesigenic dyskinesia 3 with or without generalized epilepsy | Enrichment | KCNMA1 | 2.07 |
| 67 | Leber congenital amaurosis 13 | Enrichment | GPHN | 2.07 |
| 68 | Glycosylphosphatidylinositol biosynthesis defect 17 | Enrichment | GPHN | 2.07 |
| 69 | Syndromic x-linked intellectual disability najm type | Enrichment | CASK | 2.07 |
| 70 | Cerebellar disease | Enrichment | CASK | 2.07 |
| 71 | Intellectual developmental disorder, autosomal dominant 30, with speech delay and behavioral abnormalities | Enrichment | ATP2B1 | 2.07 |
| 72 | Arachnoid cyst | Enrichment | GPHN | 2.07 |
| 73 | Undetermined early-onset epileptic encephalopathy | Enrichment | GABBR2, GABRG2 | 1.95 |
| 74 | Astigmatism | Enrichment | GRIN2B | 1.94 |
| 75 | Auriculocondylar syndrome 1 | Enrichment | PLCB4 | 1.94 |
| 76 | Tobacco addiction | Enrichment | GABBR2 | 1.94 |
| 77 | Macular dystrophy with or without cone dysfunction | Enrichment | GPHN | 1.94 |
| 78 | Autosomal dominant nocturnal frontal lobe epilepsy | Enrichment | GABRG2 | 1.94 |
| 79 | Hereditary elliptocytosis | Enrichment | EPB41 | 1.94 |
| 80 | Anemia, congenital, nonspherocytic hemolytic, 1 | Enrichment | CASK | 1.84 |
| 81 | Hemophagocytic lymphohistiocytosis, familial, 1 | Enrichment | STXBP2 | 1.84 |
| 82 | Hyperekplexia | Enrichment | GPHN | 1.84 |
| 83 | Self-limited infantile epilepsy | Enrichment | KCNQ2 | 1.84 |
| 84 | Sleep disorder | Enrichment | GRIN2B | 1.84 |
| 85 | Melanoma, uveal | Enrichment | PLCB4 | 1.77 |
| 86 | Pierre robin syndrome | Enrichment | ATP2B1 | 1.77 |
| 87 | Anxiety | Enrichment | GPHN | 1.77 |
| 88 | Childhood absence epilepsy | Enrichment | GABRG2 | 1.77 |
| 89 | Autism | Enrichment | ATP2B1, CAMK2G | 1.74 |
| 90 | Rett syndrome | Enrichment | GABBR2 | 1.70 |
| 91 | Lennox-gastaut syndrome | Enrichment | GABRG2 | 1.64 |
| 92 | Developmental and epileptic encephalopathy 14 | Enrichment | KCNQ2 | 1.59 |
| 93 | Dravet syndrome | Enrichment | GABRG2 | 1.55 |
| 94 | Epicanthus | Enrichment | KCNQ2 | 1.47 |
| 95 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | ATP2B1 | 1.43 |
| 96 | Clubfoot | Enrichment | ATP2B1 | 1.43 |
| 97 | Chromosome 1p36 deletion syndrome | Enrichment | PRKCZ | 1.43 |
| 98 | Congenital nervous system abnormality | Enrichment | ANK3, CASK | 1.43 |
| 99 | Nervous system disease | Enrichment | ANK3, CASK | 1.43 |
| 100 | Autism spectrum disorder | Enrichment | GRIN2B, KCNMA1 | 1.41 |
| 101 | Medulloblastoma | Enrichment | ANK3 | 1.40 |
| 102 | Periventricular nodular heterotopia | Enrichment | ATP2B1 | 1.40 |
| 103 | Generalized epilepsy with febrile seizures plus | Enrichment | GABRG2 | 1.40 |
| 104 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | CDH2 | 1.40 |
| 105 | Corpus callosum, agenesis of | Enrichment | CDH2 | 1.37 |
| 106 | Isolated corpus callosum agenesis | Enrichment | CDH2 | 1.37 |
| 107 | Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome | Enrichment | CDH2 | 1.37 |
| 108 | Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay | Enrichment | CASK | 1.35 |
| 109 | Isolated congenital microcephaly | Enrichment | CASK | 1.35 |
| 110 | Microcephaly | Enrichment | CASK, GRIN2B | 1.31 |
| 111 | Arteriovenous malformations of the brain | Enrichment | CDH2 | 1.27 |
| 112 | Craniosynostosis | Enrichment | GRIN2B | 1.25 |
| 113 | Mitochondrial complex iv deficiency, nuclear type 1 | Enrichment | STXBP2 | 1.21 |
| 114 | Autoinflammatory disease | Enrichment | STXBP2 | 1.18 |
| 115 | Scoliosis | Enrichment | GRIN2B | 1.18 |
| 116 | Auditory neuropathy | Enrichment | CDH2 | 1.14 |
| 117 | Stargardt disease 1 | Enrichment | GPHN | 1.08 |
| 118 | Dystonia | Enrichment | CASK | 1.02 |
| 119 | Eye disease | Enrichment | GPHN | 1.02 |
| 120 | Non-syndromic x-linked intellectual disability | Enrichment | CASK | 1.01 |
| 121 | Developmental and epileptic encephalopathy | Enrichment | KCNQ2 | 1.01 |
| 122 | Epilepsy | Enrichment | GRIN2B | 0.96 |
| 123 | Spastic ataxia | Enrichment | DAB1 | 0.85 |
| 124 | Cone-rod dystrophy 2 | Enrichment | GPHN | 0.75 |
| 125 | Leber plus disease | Enrichment | GPHN | 0.62 |
| 126 | Retinitis pigmentosa | Enrichment | GPHN | 0.34 |
| 127 | Hereditary retinal dystrophy | Enrichment | GPHN | 0.24 |
| 128 | Fundus dystrophy | Enrichment | GPHN | 0.24 |